세계의 안근 마비 시장 보고서(2025년)

Ophthalmoplegia refers to the paralysis or weakness of one or more muscles responsible for eye movement. This condition can affect both voluntary and involuntary eye movements and may be caused by neurological disorders, muscle diseases, or vascular conditions.

The main types of ophthalmoplegia include external ophthalmoplegia and internuclear ophthalmoplegia. External ophthalmoplegia involves the paralysis or weakness of the extraocular muscles, leading to impaired eye movement and drooping eyelids. It is treated with surgery or drug therapy, and the treatments are utilized by end-users such as hospitals, clinics, and ambulatory care centers.

The ophthalmoplegia market research report is one of a series of new reports from The Business Research Company that provides ophthalmoplegia market statistics, including the ophthalmoplegia industry global market size, regional shares, competitors with the ophthalmoplegia market share, detailed ophthalmoplegia market segments, market trends, and opportunities, and any further data you may need to thrive in the ophthalmoplegia industry. This ophthalmoplegia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ophthalmoplegia market size has grown rapidly in recent years. It will grow from $1.68 billion in 2024 to $1.85 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth during the historic period can be attributed to the rising prevalence of neurological disorders, the expanding aging population, the growth of specialty clinics and hospitals, increasing demand for early diagnosis and treatment, a higher number of clinical trials, and greater healthcare insurance coverage.

The ophthalmoplegia market size is expected to see rapid growth in the next few years. It will grow to $2.72 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth during the forecast period can be attributed to the rising prevalence of neurological disorders, an increasing aging population, growing awareness of eye movement disorders, higher healthcare expenditure, increased investment in healthcare by key players, and a growing patient population with diabetes and hypertension. Key trends during this period include advancements in diagnostic technologies, the development of novel therapeutic approaches, strategic collaborations and partnerships, technological innovations in eye tracking devices, and the development of muscle-strengthening drugs.

The increasing incidence of neurological disorders is expected to drive the growth of the ophthalmoplegia market. Neurological disorders affect the nervous system, including the brain, spinal cord, and nerves, leading to symptoms such as muscle weakness, coordination problems, and cognitive difficulties. The rising prevalence of these disorders is linked to genetic factors, which make individuals more vulnerable to conditions such as Alzheimer's and Parkinson's disease, as well as lifestyle changes such as poor diet, lack of physical activity, and chronic stress, all of which contribute to neurodegeneration and cognitive decline. Ophthalmoplegia plays a role in diagnosing neurological disorders such as Alzheimer's, multiple sclerosis, and stroke by identifying impaired eye muscle control, which indicates dysfunction in the nervous system. For example, in March 2023, the Alzheimer's Association, a U.S.-based nonprofit organization, reported that 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, with projections estimating this number to rise to 13.8 million by 2060. As a result, the increasing prevalence of neurological disorders is contributing to the growth of the ophthalmoplegia market.

The growth of the ophthalmoplegia market is also being fueled by the rising prevalence of autoimmune conditions. Autoimmune diseases occur when the immune system mistakenly attacks the body's own healthy cells, leading to inflammation and tissue damage. These diseases are becoming more common due to genetic factors that make some individuals more prone to immune system dysfunction, combined with environmental triggers such as infections, stress, and lifestyle factors. Ophthalmoplegia can be particularly helpful in diagnosing autoimmune disorders, as it helps identify underlying immune system issues and allows for targeted treatments that address both the muscular paralysis and the autoimmune condition. For example, in November 2024, Versorgungsatlas.de, a Germany-based organization, reported that in 2022, 6,304,340 of the 73,241,305 insured individuals were diagnosed with at least one autoimmune disease, resulting in a prevalence rate of 8.61%. Consequently, the rising prevalence of autoimmune conditions is driving the growth of the ophthalmoplegia market.

The increasing number of head injuries or trauma cases is expected to further propel the ophthalmoplegia market. Head injuries or trauma refer to damage to the scalp, skull, or brain caused by external forces such as falls, accidents, or impacts. These injuries are becoming more common due to factors such as the rise in road accidents, with high-speed collisions, lack of helmet use, and reckless driving contributing to an increased risk of severe head injuries. Other factors such as workplace accidents, falls, sports injuries, and violence also contribute to the growing incidence of traumatic brain injuries. Ophthalmoplegia can help assess head injuries or trauma by detecting potential neurological damage through impaired eye movement, which allows for early diagnosis and intervention. For instance, in 2023, a report by the Wisconsin Department of Health Services, a U.S. government agency, showed a 3% increase in traumatic injuries caused by assault compared to 2022, with cases rising from 1,544 in 2022 to 1,584 in 2023. As such, the increasing cases of head injuries and trauma are driving the growth of the ophthalmoplegia market.

Major players in the ophthalmoplegia market are Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Medline Industries Inc., Regeneron Pharmaceuticals Inc., Carl Zeiss AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Bayer AG, Santen Pharmaceutical Co. Ltd., Oculis Holding AG, Innovative Pharmaceuticals Pvt. Ltd., Clearside Biomedical Inc., Altacor Limited, Azura Ophthalmics Ltd., ViGeneron GmbH, Amritt Inc., GenSight Biologics SA, EyeBio Inc., Opthea Limited.

North America was the largest region in the ophthalmoplegia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ophthalmoplegia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ophthalmoplegia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ophthalmoplegia market consists of revenues earned by entities by providing services such as diagnosis and imaging services, neurological and ophthalmic evaluations, genetic testing and counselling, and telemedicine consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The ophthalmoplegia market also includes sales of eye patches and prisms, neuromuscular electrical stimulation (NMES) devices, corticosteroids, immunosuppressants, and botulinum toxin injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ophthalmoplegia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ophthalmoplegia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ophthalmoplegia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ophthalmoplegia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: External Opthalmoplegia; Internuclear Opthalmoplegia
• 2) By Treatment: Surgery; Drug Treatment
• 3) By End-User: Hospitals; Clinics; Ambulatory Clinics
• Sub Segments:
• 1) By External Ophthalmoplegia: Chronic Progressive External Ophthalmoplegia (CPEO); Myasthenic External Ophthalmoplegia; Mitochondrial Myopathy-Associated External Ophthalmoplegia
• 2) By Internuclear Ophthalmoplegia: Unilateral Internuclear Ophthalmoplegia; Bilateral Internuclear Ophthalmoplegia
• Companies Mentioned: Hoffmann-La Roche Ltd.; AbbVie Inc.; Novartis AG; Medline Industries Inc.; Regeneron Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ophthalmoplegia Market Characteristics

3. Ophthalmoplegia Market Trends And Strategies

4. Ophthalmoplegia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Ophthalmoplegia Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ophthalmoplegia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ophthalmoplegia Market Growth Rate Analysis
• 5.4. Global Ophthalmoplegia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ophthalmoplegia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ophthalmoplegia Total Addressable Market (TAM)

6. Ophthalmoplegia Market Segmentation

• 6.1. Global Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• External Opthalmoplegia
• Internuclear Opthalmoplegia
• 6.2. Global Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Drug Treatment
• 6.3. Global Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Clinics
• 6.4. Global Ophthalmoplegia Market, Sub-Segmentation Of External Ophthalmoplegia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Progressive External Ophthalmoplegia (CPEO)
• Myasthenic External Ophthalmoplegia
• Mitochondrial Myopathy-Associated External Ophthalmoplegia
• 6.5. Global Ophthalmoplegia Market, Sub-Segmentation Of Internuclear Ophthalmoplegia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Unilateral Internuclear Ophthalmoplegia
• Bilateral Internuclear Ophthalmoplegia

7. Ophthalmoplegia Market Regional And Country Analysis

• 7.1. Global Ophthalmoplegia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ophthalmoplegia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ophthalmoplegia Market

• 8.1. Asia-Pacific Ophthalmoplegia Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ophthalmoplegia Market

• 9.1. China Ophthalmoplegia Market Overview
• 9.2. China Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ophthalmoplegia Market

• 10.1. India Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ophthalmoplegia Market

• 11.1. Japan Ophthalmoplegia Market Overview
• 11.2. Japan Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ophthalmoplegia Market

• 12.1. Australia Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ophthalmoplegia Market

• 13.1. Indonesia Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ophthalmoplegia Market

• 14.1. South Korea Ophthalmoplegia Market Overview
• 14.2. South Korea Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ophthalmoplegia Market

• 15.1. Western Europe Ophthalmoplegia Market Overview
• 15.2. Western Europe Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ophthalmoplegia Market

• 16.1. UK Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ophthalmoplegia Market

• 17.1. Germany Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ophthalmoplegia Market

• 18.1. France Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ophthalmoplegia Market

• 19.1. Italy Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ophthalmoplegia Market

• 20.1. Spain Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ophthalmoplegia Market

• 21.1. Eastern Europe Ophthalmoplegia Market Overview
• 21.2. Eastern Europe Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ophthalmoplegia Market

• 22.1. Russia Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ophthalmoplegia Market

• 23.1. North America Ophthalmoplegia Market Overview
• 23.2. North America Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ophthalmoplegia Market

• 24.1. USA Ophthalmoplegia Market Overview
• 24.2. USA Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ophthalmoplegia Market

• 25.1. Canada Ophthalmoplegia Market Overview
• 25.2. Canada Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ophthalmoplegia Market

• 26.1. South America Ophthalmoplegia Market Overview
• 26.2. South America Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ophthalmoplegia Market

• 27.1. Brazil Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ophthalmoplegia Market

• 28.1. Middle East Ophthalmoplegia Market Overview
• 28.2. Middle East Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ophthalmoplegia Market

• 29.1. Africa Ophthalmoplegia Market Overview
• 29.2. Africa Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ophthalmoplegia Market Competitive Landscape And Company Profiles

• 30.1. Ophthalmoplegia Market Competitive Landscape
• 30.2. Ophthalmoplegia Market Company Profiles
  • 30.2.1. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Ophthalmoplegia Market Other Major And Innovative Companies

• 31.1. Carl Zeiss AG
• 31.2. Bausch Health Companies Inc.
• 31.3. Sun Pharmaceutical Industries Limited
• 31.4. Bayer AG
• 31.5. Santen Pharmaceutical Co. Ltd.
• 31.6. Oculis Holding AG
• 31.7. Innovative Pharmaceuticals Pvt. Ltd.
• 31.8. Clearside Biomedical Inc.
• 31.9. Altacor Limited
• 31.10. Azura Ophthalmics Ltd.
• 31.11. ViGeneron GmbH
• 31.12. Amritt Inc.
• 31.13. GenSight Biologics SA
• 31.14. EyeBio Inc.
• 31.15. Opthea Limited

32. Global Ophthalmoplegia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ophthalmoplegia Market

34. Recent Developments In The Ophthalmoplegia Market

35. Ophthalmoplegia Market High Potential Countries, Segments and Strategies

• 35.1 Ophthalmoplegia Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ophthalmoplegia Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ophthalmoplegia Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer